Critical Path Institute (C-Path) is pleased to welcome Kay Holcombe to its Board of Directors. Recently retired as Senior Vice President for Science Policy at the Biotechnology Innovation Organization (BIO), Ms. Holcombe brings to the Board her extensive experience in health care and regulatory policy, a history of collaboration with US regulatory agencies, and broad knowledge of government initiatives that affect the biotechnology and pharmaceutical industries.
TUCSON, Ariz., Jan. 16, 2018 — HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced that it intends to offer and sell, subject to market and other conditions, 10,000,000 shares of its common stock in an underwritten public offering.
The Patient Safety Movement Foundation Board of Directors has selected RightBio Metrics technology as a finalist for the Patient Safety Innovation Awards. There were more than 50 submissions and RightBio Metrics was selected as one of three finalists.
World-renowned researchers and science aficionados converge at valley restaurants
Amelia Gallitano, MD, PhD, a physician-scientist at the University of Arizona College of Medicine – Phoenix, has received a grant to develop a novel diagnostic test for schizophrenia.